Polygenic risk scores enhance prediction of atrial fibrillation disease progression: an analysis of the UK Biobank

Heart, Artery and Coronary DiseasesLipid-Lowering Drugs

Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk: UK Biobank Study

J Am Coll Cardiol

Farah R, Kim MS, Truong B, Sui Y, Cho SMJ, Urbut SM, Patel A, Ridker PM, Natarajan P, Fahed AC

doi: 10.1016/j.jacc.2026.01.076

Atrial Fibrillation

Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

Clin Res Cardiol

Menichelli D, Gazzaniga G, Poli D, Palareti G, Antonucci E, Pani A, Pignatelli P, Pastori D, START2 Register Investigators

doi: 10.1007/s00392-025-02765-7

Atrial FibrillationHeart Failure

External Validation of the REACT-HF Score for Predicting Heart Failure in Patients With Atrial Fibrillation

J Am Heart Assoc

Moschovitis G, Rigamonti E, Wiencierz A, Coslovsky M, Blum S, De Perna ML, Mayer-Melchiorre P, Vassalli G, Pedrazzini G, Healey JS, Reichlin T, Rodondi N, Müller A, Beer JH, Conte G, Stuber M, Schwenkglenks M, Mahfoud F, Sticherling C, Conen D, Osswald S, Kühne M, Krisai P, Swiss‐AF and BEAT‐AF Investigators

doi: 10.1161/JAHA.125.043058

Atrial Fibrillation

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Heart Rhythm

Boriani G, McIntyre WF, Ramasundarahettige C, Proietti M, Glotzer TV, Diemberger I, Nielsen JC, Essebag V, Granger CB, Sandhu RK, Benezet-Mazuecos J, Mabo P, Coutu B, Wong JA, Gold MR, Lopes RD, Healey JS, ARTESiA Investigators

doi: 10.1016/j.hrthm.2025.07.002

Further Publications

Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis

Heart

Kiliç ME, Arayici ME, Yilancioglu RY, Turan OE, Ozcan EE, Yilmaz MB

doi: 10.1136/heartjnl-2025-326174

Atrial Fibrillation

Atrial fibrillation density as a biomarker for ischaemic stroke risk prediction

Eur Heart J

Rosman L, Wang K, Sarkar S, Ziegler PD, Passman RS

doi: 10.1093/eurheartj/ehag203

Atrial Fibrillation

Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis

Eur Heart J

Raveendra K, Nadarajah R, Larvin H, Farooq M, Haris M, Cutting U, Kang J, Wilkinson C, Dalakoti M, Kotecha D, Lip GYH, Boriani G, Camm AJ, Van Gelder IC, Wu J, Gale CP

doi: 10.1093/eurheartj/ehag021

Atrial FibrillationHeart, Artery and Coronary Diseases

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial

JAMA Cardiol

Yamaguchi J, Arashi H, Hagiwara N, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Matsui K, Ogawa H, AFIRE Investigators

doi: 10.1001/jamacardio.2025.2611

Atrial Fibrillation

Identification of Clinical Risk Factors for Arrhythmia Recurrence in Atrial Fibrillation Patients Undergoing Catheter Ablation: A Systematic review and Meta-analysis

Heart Rhythm

Chan KWP, Yu DSF, Ho JWK, Wong CWY, Li PWC

doi: 10.1016/j.hrthm.2026.04.046

Related content

Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk: UK Biobank Study

Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

External Validation of the REACT-HF Score for Predicting Heart Failure in Patients With Atrial Fibrillation

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis

Atrial fibrillation density as a biomarker for ischaemic stroke risk prediction

Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial

Identification of Clinical Risk Factors for Arrhythmia Recurrence in Atrial Fibrillation Patients Undergoing Catheter Ablation: A Systematic review and Meta-analysis